Showing items 101–116
PRO-ADRENOMEDULLIN OR FRAGMENT THEREOF IN PATIENTS INFECTED WITH CORONA VIRUS AND…
Application WO-2021185785-A1
World Intellectual Property Organisation (WIPO)
Use of angiotensin II type 2 receptor agonist
Grant US-11123329-B1
United States of America
MOLECULES THAT BIND TO SARS-CoV-2
Application WO-2021183947-A1
World Intellectual Property Organisation (WIPO)
ENGINEERED NUCLEIC ACIDS AND USES THEREOF
Application WO-2021183502-A1
World Intellectual Property Organisation (WIPO)
ANTIGEN SPECIFIC EPITOPE–BASED ANTI-INFECTIVE VACCINES
Application WO-2021181390-A1
World Intellectual Property Organisation (WIPO)
IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
Application WO-2021178637-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME
Application WO-2021173753-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME
Application EP-3872091-A1
European Patent Office
VACCINE COMPOSITIONS FOR PREVENTING CORONAVIRUS DISEASE
Application WO-2021168318-A1
World Intellectual Property Organisation (WIPO)
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV…
Application WO-2021163265-A1
World Intellectual Property Organisation (WIPO)
MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND VACCINES
Application WO-2021160850-A1
World Intellectual Property Organisation (WIPO)
PRIMER SETS, BIOMARKERS, KIT AND APPLICATIONS THEREOF
Application WO-2021156882-A1
World Intellectual Property Organisation (WIPO)
Detection of antibodies against Sarsr-Cov
Grant DE-202020005492-U1
Germany
DETECTION OF ANTIBODIES TO SARSR-COV
Application EP-3800473-A1
European Patent Office
A METHOD AND REAGENTS FOR THE DIAGNOSIS OF SARS-COV-2
Application EP-3715847-A1
European Patent Office
Showing items 101–116